SCHEMBL950916

SCHEMBL950916

CCCOc1ccc(C(=O)OCC)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 3/20 0.66
▸ TDP1 Q9NUW8 2/20 0.66
▸ PLK1 P53350 1/20 0.60
▸ ESR1 P03372 2/20 0.59
▸ CA12 O43570 1/20 0.59
▸ CA1 P00915 1/20 0.59
▸ CA2 P00918 1/20 0.59
▸ CA7 P43166 1/20 0.59
▸ CA9 Q16790 1/20 0.59
▸ ESR2 Q92731 1/20 0.59
▸ CA14 Q9ULX7 1/20 0.59
▸ MAPT P10636 5/20 0.58
▸ ADRB2 P07550 1/20 0.58
▸ ADRB1 P08588 1/20 0.58
▸ ADRB3 P13945 1/20 0.58
▸ LMNA P02545 2/20 0.58
▸ CYP1A2 P05177 1/20 0.58
▸ CYP3A4 P08684 1/20 0.58
▸ MAOA P21397 1/20 0.58
▸ THRB P10828 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6608311 0.95 KCNH2 (0.64) L3MBTL1TDP1PLK1ESR1CA12
SCHEMBL5166263 0.93 TDP1 (0.66) L3MBTL1TDP1ESR1CA12CA1
SCHEMBL6701399 0.93 TDP1 (0.74) L3MBTL1TDP1ESR1CA12CA1
SCHEMBL4363022 0.91 ALDH1A1 (0.68) L3MBTL1TDP1PLK1ESR1MAPT
SCHEMBL18821708 0.91 MAPT (0.62) L3MBTL1TDP1PLK1ESR1CA12
SCHEMBL5218267 0.90 TSHR (0.66) L3MBTL1TDP1ESR1MAPTLMNA
Benzene SCHEMBL27936904 0.90 TDP1 (0.67) L3MBTL1TDP1ESR1MAPTLMNA
SCHEMBL11126885 0.88 TP53 (0.69) L3MBTL1TDP1MAPTLMNASTS
SCHEMBL12948055 0.88 TDP1 (0.61) L3MBTL1TDP1ESR1CA12CA1
SCHEMBL15060975 0.88 KCNH2 (0.67) L3MBTL1TDP1ESR1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2958950-B1 AN IMPROVED MAGNESIUM DICHLORIDE SUPPORTED TITANIUM CATALYST COMPOSITION FOR POLYOLEFIN POLYMERIZATION RELIANCE INDUSTRIES LTD (IN) 2019-09-11 — — EP claimed
US-20160002372-A1 Magnesium Dichloride Supported Titanium Catalyst Composition for Polyolefin Polymerization RELIANCE INDUSTRIES LIMITED (IN) 2016-01-07 — — US claimed
EP-2958950-A2 AN IMPROVED MAGNESIUM DICHLORIDE SUPPORTED TITANIUM CATALYST COMPOSITION FOR POLYOLEFIN POLYMERIZATION Reliance Industries Limited (IN) 2015-12-30 — — EP claimed
CN-102834420-B Internal and external donor compounds for olefin polymerization catalysts ii BASF CORP. (US) 2014-10-22 — — CN claimed
WO-2014128715-A2 AN IMPROVED MAGNESIUM DICHLORIDE SUPPORTED TITANIUM CATALYST COMPOSITION FOR POLYOLEFIN POLYMERIZATION RELIANCE INDUSTRIES LIMITED (IN) 2014-08-28 — — WO claimed
US-8569195-B2 Internal and external donor compounds for olefin polymerization catalysts II BASF CORPORATION (US) 2013-10-29 — — US claimed
CN-102834420-A Internal and external donor compounds for olefin polymerization catalysts ii BASF CORP 2012-12-19 — — CN claimed
EP-2958950-B1 AN IMPROVED MAGNESIUM DICHLORIDE SUPPORTED TITANIUM CATALYST COMPOSITION FOR POLYOLEFIN POLYMERIZATION RELIANCE INDUSTRIES LTD (IN) 2019-09-11 — — EP disclosed
US-9828338-B2 Carbamate derivatives of lactam based N-acylethanolamine acid amidase (NAAA) inhibitors THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2017-11-28 — — US disclosed
EP-2782938-B1 HIGH ACTIVITY CATALYST FOR OLEFIN POLYMERIZATION BASF CORP (US) 2016-08-31 — — EP disclosed
US-20160068482-A1 CARBAMATE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2016-03-10 — — US disclosed
US-20160002372-A1 Magnesium Dichloride Supported Titanium Catalyst Composition for Polyolefin Polymerization RELIANCE INDUSTRIES LIMITED (IN) 2016-01-07 — — US disclosed
EP-2958950-A2 AN IMPROVED MAGNESIUM DICHLORIDE SUPPORTED TITANIUM CATALYST COMPOSITION FOR POLYOLEFIN POLYMERIZATION Reliance Industries Limited (IN) 2015-12-30 — — EP disclosed
EP-1472215-A2 (OXIME)CARBAMOYL FATTY ACID AMIDE HYDROLASE INHIBITORS Bristol-Myers Squibb Company (US) 2004-11-03 — — EP disclosed
US-20030195226-A1 (Oxime)carbamoyl fatty acid amide hydrolase inhibitors SIT SING-YUEN (US) 2003-10-16 — — US disclosed
WO-2003065989-A2 (OXIME)CARBAMOYL FATTY ACID AMIDE HYDROLASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2003-08-14 — — WO disclosed
CN-1135767-A Shield ultraviolet compounded particle and production method thereof and cosmetics thereof KAO CORP (JP) 1996-11-13 — — CN disclosed
CN-1007248-B PROCESS FOR MANUFACTURING OF FLOOD SUGAR REDUCING MEDICINE-THIAZOLIDINEDIONS PFIZER (US) 1990-03-21 — — CN disclosed
CN-86104075-A Preparation method of hypoglycemic agent-thiazolidinedione — 1987-03-11 — — CN disclosed
US-4136165-A SUNSCREEN AGENTS HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1979-01-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160068482-A1 CARBAMATE DERIVATIVES OF LACTAM BASED N-ACYLETHANOLAMINE ACID AMIDASE (NAAA) INHIBITORS NAAA, FAAH, FAAH2 L3MBTL1 4342/4885TDP1 3834/4885PLK1 3144/4885
US-20030195226-A1 (Oxime)carbamoyl fatty acid amide hydrolase inhibitors FAAH, FAAH2, NCEH1 L3MBTL1 2799/4885TDP1 949/4885PLK1 4823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback